image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Tarsus - Exposure to fast growing emerging markets reaches 50% revenues

February 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TRS
  • Price:
  • 204.5p
Exhibition organiser, Tarsus is a company, which has served TMI well, with our previous main recommendations at 104p in June '09 and again at 120p in November the following year, well in the money. The company is a favourite of ours because it operates several market leading events in sectors exhibiting dynamic growth and their “must have” as opposed to “nice to have” nature means re-bookings run at high levels while cash is received up to a year in advance.However, our re-recommendation at this juncture is more reflective of the fact that Tarsus has just achieved a long-held target to derive 50% revenues from emerging markets and management are now switching their focus to accelerating eps growth towards 1 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X